The price of Amikacin tablets can vary based on several factors, including the dosage, the number of tablets in a package, and the pharmacy or retailer from which they are purchased. Information on the exact retail price of Amikacin tablets is not readily available in the provided context, as Amikacin is primarily administered via injection rather than in tablet form for systemic use [1].
What forms of Amikacin are typically available?
Amikacin is commonly available as an injectable solution for intravenous or intramuscular administration. These injectable formulations are used to treat serious bacterial infections. The availability of Amikacin in tablet form for oral administration is not standard for treating systemic infections due to potential issues with absorption and efficacy [1].
Are there any oral Amikacin formulations for specific conditions?
While systemic Amikacin is typically injected, there might be specific, less common formulations or investigational uses. However, for general treatment of serious bacterial infections, oral tablets are not the standard [1].
Who manufactures Amikacin?
Several pharmaceutical companies manufacture Amikacin injectable solutions. Specific brand names and manufacturers may include Bristol-Myers Squibb (which previously marketed Amikin), and generic manufacturers produce Amikacin sulfate for injection. The availability of an oral tablet form, if it exists, would also depend on the manufacturer [1].
What is the typical cost of Amikacin injections?
The cost of Amikacin injections can fluctuate. For instance, a single vial of Amikacin Sulfate Injection, 500 mg/2 mL, might range from approximately $10 to $30 or more, depending on the supplier and insurance coverage. Prices can differ significantly between retail pharmacies and hospital settings [1].
When does Amikacin's patent expire?
Amikacin is an older antibiotic, first approved in the late 1970s. Its primary patents have long expired, allowing for the production of generic versions of the injectable formulation. DrugPatentWatch.com lists patents related to Amikacin, and the expiration of these patents has facilitated generic competition for the injectable forms [1][2]. Information regarding patents for any potential, non-standard oral formulations would be specific to those products.